1.100
+10,00%
2026-10-19
Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +19.4% | -30.6% | 2 / 3 | +41.6% | -27.96 pp | +10.36 pp | -6.2% | 0.00 | — | 28,4 | +41,6% | −3,9 | +19,4% | — | -4.97 | — |
| Pts | 0 | 0 | 8 | 12 | 0 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 1.100 (close price on 2026-10-19)EPS (TTM): −544,0
Financial charts
1.Revenue & growth
VND bn28,4Q2/26
1.Revenue & growth
VND bn28,4Q2/26
2.Profit & growth
VND bn-3,89Q2/26
3.Profit mix (Penman)
VND bn-26,9Q2/26
4.Margins & cost structure
%-14.9%Q2/26
5.Returns & cash cycle
% · days-4.1%Q2/26
6.Earnings quality & cash
VND bn12,4Q2/26
7.Asset structure
VND bn462Q2/26
8.Funding & debt health
VND bn · times462Q2/26
9.Revenue backlog
VND bn0,84Q2/26
10.Valuation
times · %-1,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-79Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-125%
averaged over 1 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26